A detailed history of Polar Capital Holdings PLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 675,000 shares of MIRM stock, worth $29.5 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
675,000
Previous 741,049 8.91%
Holding current value
$29.5 Million
Previous $25.3 Million 3.9%
% of portfolio
0.16%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$33.68 - $44.74 $2.22 Million - $2.96 Million
-66,049 Reduced 8.91%
675,000 $26.3 Million
Q2 2024

Aug 14, 2024

BUY
$23.57 - $34.85 $2.74 Million - $4.04 Million
116,049 Added 18.57%
741,049 $25.3 Million
Q4 2023

Feb 14, 2024

SELL
$27.14 - $34.93 $14.9 Million - $19.2 Million
-550,000 Reduced 46.81%
625,000 $18.5 Million
Q3 2023

Nov 14, 2023

BUY
$24.63 - $32.85 $6.16 Million - $8.21 Million
250,000 Added 27.03%
1,175,000 $37.1 Million
Q2 2023

Dec 13, 2023

SELL
$23.51 - $30.09 $115,363 - $147,651
-4,907 Reduced 0.53%
925,000 $23.9 Million
Q2 2023

Aug 14, 2023

SELL
$23.51 - $30.09 $115,363 - $147,651
-4,907 Reduced 0.53%
925,000 $23.9 Million
Q1 2023

Dec 13, 2023

SELL
$19.19 - $24.1 $4.7 Million - $5.91 Million
-245,093 Reduced 20.86%
929,907 $22.3 Million
Q1 2023

May 15, 2023

BUY
$19.19 - $24.1 $1.44 Million - $1.81 Million
75,000 Added 8.77%
929,907 $22.3 Million
Q4 2022

Feb 14, 2023

SELL
$17.59 - $23.83 $5.72 Million - $7.74 Million
-325,000 Reduced 27.54%
854,907 $16.7 Million
Q3 2022

Nov 14, 2022

SELL
$19.98 - $29.44 $649,849 - $957,536
-32,525 Reduced 2.68%
1,179,907 $24.8 Million
Q2 2022

Aug 15, 2022

BUY
$18.42 - $27.5 $4.4 Million - $6.56 Million
238,723 Added 24.52%
1,212,432 $23.6 Million
Q1 2022

May 16, 2022

BUY
$15.5 - $23.93 $15.1 Million - $23.3 Million
973,709 New
973,709 $21.4 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.61B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.